Remdesivir in The Treatment of COVID-19
Author:
- Karen RosenbergKRKaren Rosenberg
- 1 January 2021
- journal article
- editorial
- Published by Wolters Kluwer Health in AJN, American Journal of Nursing
- Vol. 121 (1) , 55
Abstract
According to this study: The antiviral remdesivir is superior to placebo in the treatment of patients hospitalized with COVID-19. A variety of therapeutic approaches are needed to continue to improve outcomes in COVID-19 patients.Keywords
This publication has 1 reference indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020